Case report of early-onset epileptic encephalopathy caused by FGF12 gene mutation
10.3760/cma.j.cn101070-20200629-01087
- VernacularTitle:FGF12基因突变致早发性癫痫性脑病1例
- Author:
Hongwei ZHANG
;
Ruifeng JIN
;
Yong LIU
;
Jianguo SHI
;
Meng WANG
;
Ruopeng SUN
;
Zaifen GAO
;
Yao MENG
;
Guifu GENG
- From:
Chinese Journal of Applied Clinical Pediatrics
2021;36(2):142-145
- CountryChina
- Language:Chinese
-
Abstract:
The data of a child with early-onset epileptic encephalopathy in Qilu Children′s Hospital of Shandong University in February 2020 were analyzed retrospectively.The child was a 4-month-old girl, who was admitted to the hospital because of " repeated convulsions for 4 months and feeding difficulty for 1 month" at the age of 4 months.The patient suffered from epilepsy 1 day after birth, and the epilepsy type was tonic seizures.Severe developmental retardation was observed in the patient.Electroencephalogram showed multifocal discharge, which then turned to hypsarrhythmia.The cranial imaging was negative.Feeding difficulty occurred at the age of 3 months.The genetic testing revealed a de novo heterozygous missense mutation in the FGF12 gene (Arg114His). Various antiepileptic drugs and ketogenic diet were ineffective.There was no attack in 2 months after adding Phenytoin.The child could eat on her own after seizure control, but there was no progress in intellectual and motor development.Mutations in the FGF12 gene lead to poor prognosis of early-onset epileptic encephalopathy, and the seizures are difficult to control.Sodium ion channel blockers such as Phenytoin should be used as soon as possible.
